| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1471-4159.1997.69052064.X |
| P698 | PubMed publication ID | 9349552 |
| P2093 | author name string | Beal MF | |
| Browne SE | |||
| Brown RH Jr | |||
| Kowall NW | |||
| Bowling AC | |||
| Ferrante RJ | |||
| MacGarvey U | |||
| Shinobu LA | |||
| Baik MJ | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P304 | page(s) | 2064-2074 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis | |
| P478 | volume | 69 |
| Q37960537 | 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies |
| Q35189565 | 4-hydroxynonenal and neurodegenerative diseases |
| Q64854791 | A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods |
| Q42234881 | A differential autophagy-dependent response to DNA double-strand breaks in bone marrow mesenchymal stem cells from sporadic ALS patients |
| Q74665187 | A method for direct cross-linking of DNA bases containing aromatic amino groups to proteins |
| Q33742705 | A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis |
| Q28474016 | A role for oxidized DNA precursors in Huntington's disease-like striatal neurodegeneration |
| Q35802889 | ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons |
| Q41713153 | AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro. |
| Q28267385 | Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis |
| Q34192160 | Accumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis |
| Q54568438 | Activation of STAT1 in neurons following spinal cord injury in mice. |
| Q42480875 | Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. |
| Q38741121 | Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis |
| Q37157092 | Alzheimer's disease-associated polymorphisms in human OGG1 alter catalytic activity and sensitize cells to DNA damage |
| Q59219368 | Amyotrophic lateral sclerosis |
| Q46798019 | Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms |
| Q34175381 | Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded |
| Q35048032 | Amyotrophic lateral sclerosis: progress and prospects for treatment |
| Q58694417 | An overview of DNA repair in amyotrophic lateral sclerosis |
| Q37647941 | Antioxidant gene therapy against neuronal cell death |
| Q26747375 | Astaxanthin-Producing Green Microalga Haematococcus pluvialis: From Single Cell to High Value Commercial Products |
| Q92230808 | Bilirubin Links Heme Metabolism to Neuroprotection by Scavenging Superoxide |
| Q35114490 | Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease |
| Q31389611 | Biological markers in the diagnosis and treatment of ALS. |
| Q36488715 | Biology of mitochondria in neurodegenerative diseases |
| Q73039021 | Blood oxidative stress in amyotrophic lateral sclerosis |
| Q82054090 | Bringing SOD1 into the fold |
| Q34104938 | Catalytic antioxidants and neurodegeneration |
| Q92922603 | Cellular Aging Characteristics and Their Association with Age-Related Disorders |
| Q59544347 | Chapter 9 Cellular Biological Effects of Copper/Zinc Superoxide Dismutase Mutations |
| Q64883214 | Chemical Basis of Reactive Oxygen Species Reactivity and Involvement in Neurodegenerative Diseases. |
| Q33691896 | Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects |
| Q42832662 | Contrasting antioxidant and cytotoxic effects of peroxiredoxin I and II in PC12 and NIH3T3 cells |
| Q28343973 | Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase |
| Q91712116 | Copper ion / H2O2 oxidation of Cu/Zn-Superoxide dismutase: Implications for enzymatic activity and antioxidant action |
| Q39125395 | Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice |
| Q48271891 | Cu/Zn superoxide dismutase activity at different ages in sporadic amyotrophic lateral sclerosis |
| Q89560241 | Curcumin attenuates copper-induced oxidative stress and neurotoxicity in Drosophila melanogaster |
| Q45213388 | Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. |
| Q36690697 | Cytoskeletal protein carbonylation and degradation in experimental autoimmune encephalomyelitis |
| Q48961308 | DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS. |
| Q35231353 | DJ-1 knockout augments disease severity and shortens survival in a mouse model of ALS. |
| Q48487103 | DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis |
| Q64387668 | DNA damage profiling in motor neurons: a single-cell analysis by comet assay |
| Q52349292 | DNA plasticity and damage in amyotrophic lateral sclerosis. |
| Q38612559 | DNA strand breaks and TDP-43 mislocation are absent in the murine hSOD1G93A model of amyotrophic lateral sclerosis in vivo and in vitro. |
| Q45877621 | Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. |
| Q34028507 | Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity |
| Q43054755 | Different roles of radical scavengers--ascorbate and urate in the cerebrospinal fluid of amyotrophic lateral sclerosis patients |
| Q38811833 | Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis |
| Q24544265 | Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice |
| Q48771567 | Early decrease of redox factor-1 in spinal motor neurons of presymptomatic transgenic mice with a mutant SOD1 gene |
| Q78617317 | Early decrease of survival factors and DNA repair enzyme in spinal motor neurons of presymptomatic transgenic mice that express a mutant SOD1 gene |
| Q44026113 | Early decrease of the immunophilin FKBP 52 in the spinal cord of a transgenic model for amyotrophic lateral sclerosis |
| Q44535338 | Early mitochondrial dysfunction occurs in motor cortex and spinal cord at the onset of disease in the Wobbler mouse |
| Q36902164 | Electrophilic nitro-fatty acids prevent astrocyte-mediated toxicity to motor neurons in a cell model of familial amyotrophic lateral sclerosis via nuclear factor erythroid 2-related factor activation |
| Q52651163 | Energy metabolism in ALS: an underappreciated opportunity? |
| Q42251158 | Enhanced expression of manganese-dependent superoxide dismutase in human and sheep CLN6 tissues |
| Q73289799 | Enhanced oxidative damage by the familial amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutants |
| Q28202177 | Excitotoxic and Excitoprotective Mechanisms: Abundant Targets for the Prevention and Treatment of Neurodegenerative Disorders |
| Q39823079 | Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis |
| Q60960529 | Four New Depsides Isolated from and Their Significant Nerve-Protective Activities |
| Q28206361 | From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS |
| Q33792977 | From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. |
| Q35245567 | G-quadruplex structures formed by expanded hexanucleotide repeat RNA and DNA from the neurodegenerative disease-linked C9orf72 gene efficiently sequester and activate heme |
| Q44540942 | Genetic deficiency of a mitochondrial aldehyde dehydrogenase increases serum lipid peroxides in community-dwelling females |
| Q24630117 | Getting 'Smad' about obesity and diabetes |
| Q57042709 | Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms |
| Q33742729 | Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis |
| Q34194244 | Haematococcus astaxanthin: applications for human health and nutrition |
| Q37581663 | Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence |
| Q28200851 | Hohenheim consensus workshop: copper |
| Q38057758 | Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration |
| Q35806256 | Humoral factors in ALS patients during disease progression. |
| Q74541212 | Hydrogen peroxide induces transient dephosphorylation of tau protein in cultured rat oligodendrocytes |
| Q47774981 | Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice |
| Q46935418 | ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis. |
| Q46245616 | Immunoglobulins G from Sera of Amyotrophic Lateral Sclerosis Patients Induce Oxidative Stress and Upregulation of Antioxidative System in BV-2 Microglial Cell Line |
| Q28730319 | Impact of treadmill running and sex on hippocampal neurogenesis in the mouse model of amyotrophic lateral sclerosis |
| Q47844024 | Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. |
| Q43857845 | In vivo peroxidative activity of FALS-mutant human CuZnSODs expressed in yeast |
| Q39818361 | Increased Oxidative DNA Damage in Patients With Alcohol Dependence and Its Correlation With Alcohol Withdrawal Severity |
| Q52726042 | Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation. |
| Q36750834 | Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis |
| Q48253577 | Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase |
| Q73082166 | Increased oxidative damage to DNA in ALS patients |
| Q85631552 | Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration |
| Q36717816 | Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies |
| Q41469956 | Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. |
| Q43543805 | Intrathecal cyclosporin prolongs survival of late-stage ALS mice |
| Q90391063 | LanCL1 promotes motor neuron survival and extends the lifespan of amyotrophic lateral sclerosis mice |
| Q83752871 | Levels of membrane fluidity in the spinal cord and the brain in an animal model of amyotrophic lateral sclerosis |
| Q48145528 | Lipid peroxidation scavengers prevent the carbonylation of cytoskeletal brain proteins induced by glutathione depletion |
| Q38050263 | Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain |
| Q36608461 | Lycopene |
| Q37031757 | MST1 functions as a key modulator of neurodegeneration in a mouse model of ALS |
| Q47267629 | Mechanism of Protein Carbonylation in Glutathione-Depleted Rat Brain Slices |
| Q26749169 | Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis |
| Q92534777 | Mechanisms of Immune Activation by c9orf72-Expansions in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia |
| Q34640994 | Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis |
| Q24799443 | Method for determination of (-102C>T) single nucleotide polymorphism in the human manganese superoxide dismutase promoter |
| Q38455911 | Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis |
| Q49556815 | Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease. |
| Q36741168 | Mitochondrial DNA damage and repair in neurodegenerative disorders |
| Q34502221 | Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases |
| Q40667007 | Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid |
| Q28397548 | Mitochondrial lipids in neurodegeneration |
| Q34038775 | Mitochondrial pathobiology in ALS. |
| Q35489359 | Molecular and cellular pathways of neurodegeneration in motor neurone disease |
| Q43767626 | Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients |
| Q91970420 | Motor Neuron Susceptibility in ALS/FTD |
| Q53588721 | Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. |
| Q33600152 | Motor neurone disease. |
| Q32160820 | Motor neurons rapidly accumulate DNA single-strand breaks after in vitro exposure to nitric oxide and peroxynitrite and in vivo axotomy |
| Q34308339 | Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules |
| Q47582986 | Mutation frequency is reduced in the cerebellum of Big Blue mice overexpressing a human wild type SOD1 gene |
| Q37589114 | NADPH oxidase in brain injury and neurodegenerative disorders |
| Q35833225 | NADPH oxidase mediated oxidative stress in hepatic fibrogenesis |
| Q35408649 | NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage |
| Q28546214 | Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases |
| Q35196302 | Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals |
| Q33865534 | No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice |
| Q37168739 | Nutraceuticals against Neurodegeneration: A Mechanistic Insight |
| Q37073851 | Nutrition and dietary supplements in motor neuron disease |
| Q24596378 | Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis |
| Q33305255 | Optimizing separation efficiency of 2-DE procedures for visualization of different superoxide dismutase forms in a cellular model of amyotrophic lateral sclerosis. |
| Q64982512 | Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View. |
| Q39116610 | Oxidative mitochondrial DNA damage in peripheral blood mononuclear cells is associated with reduced volumes of hippocampus and subcortical gray matter in chronically HIV-infected patients |
| Q35224677 | Oxidative stress in neurodegeneration |
| Q41763466 | Oxidative stress induced by loss of Cu,Zn-superoxide dismutase (SOD1) or superoxide-generating herbicides causes axonal degeneration in mouse DRG cultures |
| Q61804436 | Oxidative stress: the lowest common denominator of multiple diseases |
| Q34615830 | Oxidatively modified proteins in aging and disease |
| Q99555756 | PET Imaging for Oxidative Stress in Neurodegenerative Disorders Associated with Mitochondrial Dysfunction |
| Q50562013 | Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study. |
| Q35134386 | Pathoetiology of motor neuron disease: new insights from genetics and animal models |
| Q31120123 | Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein |
| Q28080057 | Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP) |
| Q38657264 | Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient |
| Q53925594 | Peroxynitrite-induced cytotoxicity in cultured astrocytes is associated with morphological changes and increased nitrotyrosine immunoreactivity. |
| Q36615226 | Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease |
| Q35125315 | Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis. |
| Q34477724 | Progress in clinical neurosciences: the evidence for ALS as a multisystems disorder of limited phenotypic expression. |
| Q36270615 | Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase |
| Q44794339 | Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study |
| Q44317892 | Protein carbonyl groups as biomarkers of oxidative stress. |
| Q35878309 | Protein carbonylation and aggregation precede neuronal apoptosis induced by partial glutathione depletion |
| Q35119660 | Protein carbonylation in human diseases |
| Q37918059 | Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis |
| Q36364363 | Quercitrin and quercetin 3-β-d-glucoside as chemical chaperones for the A4V SOD1 ALS-causing mutant |
| Q35764195 | RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1. |
| Q42011097 | RNA Granules and Diseases: A Case Study of Stress Granules in ALS and FTLD |
| Q36093828 | RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord |
| Q34243986 | Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. |
| Q58711477 | Real-time visualization of oxidative stress-mediated neurodegeneration of individual spinal motor neurons in vivo |
| Q33742737 | Redox modifier genes and pathways in amyotrophic lateral sclerosis |
| Q30446460 | Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. |
| Q27026894 | Redox regulation in amyotrophic lateral sclerosis |
| Q33945688 | Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease |
| Q34376312 | Reduced proteasomal activity contributes to the accumulation of carbonylated proteins in chronic experimental autoimmune encephalomyelitis |
| Q26740342 | Role of ROS and RNS Sources in Physiological and Pathological Conditions |
| Q34400646 | Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment |
| Q33819255 | Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis |
| Q38543012 | SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons |
| Q38186171 | SIRT1 in neurodevelopment and brain senescence |
| Q37101247 | SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration |
| Q48918632 | SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter |
| Q43762848 | Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibers isolated from G93AhumanSOD1 transgenic mice |
| Q36836734 | Shortage of lipid-radical cycles in membranes as a possible prime cause of energetic failure in aging and Alzheimer disease |
| Q38714676 | Sirt1 in cerebral ischemia |
| Q40607421 | Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease |
| Q49045082 | Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant |
| Q33919781 | Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis |
| Q40733321 | Sublethal doses of β-amyloid peptide abrogate DNA-dependent protein kinase activity |
| Q73852676 | Synthetic superoxide dismutase/catalase mimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model |
| Q28482611 | TDP-43 identified from a genome wide RNAi screen for SOD1 regulators |
| Q36681472 | Telomere shortening leads to earlier age of onset in ALS mice |
| Q38218666 | The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis. |
| Q57471221 | The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis |
| Q92460570 | The Role of the Reactive Oxygen Species Scavenger Agent, Astaxanthin, in the Protection of Cisplatin-Treated Patients Against Hearing Loss |
| Q35143367 | The basic aspects of therapeutics in amyotrophic lateral sclerosis |
| Q77892135 | The genetic and molecular mechanisms of motor neuron disease |
| Q37261104 | The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice |
| Q37466115 | The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy |
| Q45861221 | The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model |
| Q79760113 | The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs |
| Q33633778 | The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis |
| Q93014731 | Therapeutic alternative of the ketogenic Mediterranean diet to improve mitochondrial activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review |
| Q28389739 | Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling |
| Q92833446 | Three-dimensional modeling of human neurodegeneration: brain organoids coming of age |
| Q35514192 | Traditional reactive carbonyl scavengers do not prevent the carbonylation of brain proteins induced by acute glutathione depletion |
| Q38291889 | Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2). |
| Q41786075 | Tumor necrosis factor alpha-mediated nitric oxide production enhances manganese superoxide dismutase nitration and mitochondrial dysfunction in primary neurons: an insight into the role of glial cells |
| Q48355959 | VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death |
| Q30252333 | Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage |
| Q30542282 | Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis |
| Q33824784 | Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies |
| Q36904550 | Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis |
| Q64260753 | as a Model to Study the Multiple Phenotypes, Related to Genome Stability of the Fragile-X Syndrome |
| Q74233498 | iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis |
Search more.